Literature DB >> 12380880

Immunity to tetanus in male adults in Dar es Salaam, Tanzania.

S Aboud1, E F Lyamuya, E K Kristoffersen, R Matre.   

Abstract

OBJECTIVE: To determine immunity to tetanus in male blood donors with previous diphtheria-pertussis-tetanus (DPT)/tetanus toxoid (TT) vaccination.
DESIGN: A cross sectional study, conducted in September 1999.
SETTING: Blood bank, Muhimbili Medical Centre, Dar es Salaam, Tanzania.
METHODS: Using an antigen competition ELISA technique, serum tetanus anti-toxin levels in two hundred male blood donors were determined.
RESULTS: Vaccination history was absent in 43 (21.5%) blood donors, whereas 60 (30%) and 97 (48.5%) reported childhood DPT and TT vaccination, respectively. Tetanus anti-toxin was undetectable in 47 (23.5%) blood donors and the levels were below that considered protective (> or = 0.1 IU/ml) in 25 (12.5%). Among those with undetectable level, 43 (91.5%) had no vaccination history. Time after last DPT/TT vaccination correlated significantly with tetanus anti-toxin levels (r2=-0.331, p=0.001). In multivariate analysis, TT doses received and time after last vaccination explained 4.8% and 29.4%, respectively, of the variations in tetanus anti-toxin levels.
CONCLUSION: Seventy two (36%) male blood donors were susceptible to tetanus and the susceptibility was highest from 48 years. A regular TT booster dose at 10 yearly intervals is recommended to provide adequate and long lasting immunity in male adults. Proper keeping of vaccination records is emphasised.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12380880     DOI: 10.4314/eamj.v79i2.8904

Source DB:  PubMed          Journal:  East Afr Med J        ISSN: 0012-835X


  3 in total

1.  Tetanus Immunity Gaps in Children 5-14 Years and Men ≥ 15 Years of Age Revealed by Integrated Disease Serosurveillance in Kenya, Tanzania, and Mozambique.

Authors:  Heather M Scobie; Minal Patel; Diana Martin; Harran Mkocha; Sammy M Njenga; Maurice R Odiere; Sonia Pelletreau; Jeffrey W Priest; Ricardo Thompson; Kimberly Y Won; Patrick J Lammie
Journal:  Am J Trop Med Hyg       Date:  2016-12-05       Impact factor: 2.345

2.  Significance of Fas and Fas ligand in tuberculous lymphadenitis.

Authors:  Tehmina Mustafa; Stanley J Mogga; Sayoki G M Mfinanga; Odd Mørkve; Lisbet Sviland
Journal:  Immunology       Date:  2005-02       Impact factor: 7.397

3.  Multiplex Analysis of Pro- or Anti-Inflammatory Serum Cytokines and Chemokines in relation to Gender and Age among Tanzanian Tuberculous Lymphadenitis Patients.

Authors:  Tehmina Mustafa; Karl Albert Brokstad; Sayoki G Mfinanga; Harald G Wiker
Journal:  Tuberc Res Treat       Date:  2015-04-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.